What other stocks do shareholders of Urologix own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Urologix investors own include Novus Therapeutics (NVUS) , Nathan's Famous (NATH) , Medical Marijuana (MJNA) , MGM Resorts International (MGM) , Spectrum Brands (HRG) , iShares MSCI Emerging Markets ETF (EEM) , Cronos Group (CRON) , Cannabix Technologies (BLOZF) and Barnes Group (B) .

How do I buy shares of Urologix?

Shares of ULGX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:ULGX

Urologix (ULGX) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Free ULGX Stock Alerts

Compare

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: N/A
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Financials

Get Urologix alerts:

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

About Urologix

Urologix, Inc. develops, manufactures, markets, and distributes minimally invasive medical products for the treatment of obstruction and symptoms due to benign prostatic hyperplasia (BPH) in the United States. The company offers Cooled ThermoTherapy, which produces targeted microwave energy combined with a cooling mechanism to protect healthy tissue and enhance patient comfort. It also provides Prostiva RF Therapy System that delivers radio frequency energy directly into the prostate to destroy prostate tissue, reduce constriction of the urethra, and relieve BPH symptoms. It serves patients and clinicians. Urologix, Inc. was founded in 1991 and is based in Minneapolis, Minnesota.

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

ULGX Stock News Headlines

November 15, 2023 | finance.yahoo.com

Latest Market Study | Anti-Snoring Devices Market Size, Share, Trends, Industry Analysis & Forecasts, 2023-2030

July 29, 2023 | investing.com

Suoxinda Holdings Ltd (3680)

April 19, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

July 13, 2023 | investing.com

Create Capital Vietnam Limited JSC (CRC)

May 1, 2023 | finance.yahoo.com

Benign Prostate Hyperplasia (BPH) Treatment Market Report 2023: Product Launches Continue to Boost Market

March 7, 2023 | finance.yahoo.com

Urologix, Inc. (ULGX) Stock Historical Prices & Data - Yahoo Finance

See More Headlines

Receive ULGX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Urologix and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/19/2024
Fiscal Year End: 6/30/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Electromedical equipment
Sub-Industry: N/A
Current Symbol: OTCMKTS:ULGX
CUSIP: N/A
CIK: 882873
Web: www.urologix.com
Phone: (763) 475-1400
Fax: 763-404-8118
Employees: 61
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: 0.08

10 Best Stocks to Own in 2024

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

Bryon Merade
Chairman & CEO

Key Competitors

View All Competitors

ULGX Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Urologix own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Urologix investors own include Novus Therapeutics (NVUS), Nathan's Famous (NATH), Medical Marijuana (MJNA), MGM Resorts International (MGM), Spectrum Brands (HRG), iShares MSCI Emerging Markets ETF (EEM), Cronos Group (CRON), Cannabix Technologies (BLOZF) and Barnes Group (B).
How do I buy shares of Urologix?: Shares of ULGX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:ULGX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Urologix (ULGX) Stock Price, News & Analysis

About Urologix

ULGX Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

ULGX Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info